Central Nervous System Fungal Infections

LETTERS TO THE EDITOR
Deferasirox, an Iron-Chelating Agent, as Salvage Therapy for Rhinocerebral Mucormycosis
Caitlin Reed, Ashraf Ibrahim, John E. Edwards, Irwin Walot, Brad Spellberg
Experimental Therapeutics
Comparative Efficacies of Conventional Amphotericin B, Liposomal Amphotericin B (AmBisome), Caspofungin, Micafungin, and Voriconazole Alone and in Combination against Experimental Murine Central Nervous System Aspergillosis
Karl V. Clemons, Marife Espiritu, Rachana Parmar, David A. Stevens
Experimental Therapeutics
Antifungal Therapy of Experimental Cerebral Phaeohyphomycosis Due to Cladophialophora bantiana
Hail M. Al-Abdely, Laura K. Najvar, Rosie Bocanegra, John R. Graybill
Erratum
Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis
Jackie K. Imai, Gaurav Singh, Karl V. Clemons, David A. Stevens
Experimental Therapeutics
Efficacy of Posaconazole in a Murine Model of Central Nervous System Aspergillosis
Jackie K. Imai, Gaurav Singh, Karl V. Clemons, David A. Stevens
Experimental Therapeutics
SCH 56592, Amphotericin B, or Itraconazole Therapy of Experimental Murine Cerebral Phaeohyphomycosis Due toRamichloridium obovoideum (“Ramichloridium mackenziei”)
Hail M. Al-Abdely, Laura Najvar, Rosie Bocanegra, Annette Fothergill, David Loebenberg, Michael G. Rinaldi, John R. Graybill